Clinical Trial

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Study acronym: AIRITY
Recruiting
View on ClinicalTrials.gov →
Summary
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.
Protocol Amendment History 2 changes
notable Trial sites expanded: 54 -> 59 locations 2026-08-14
notable Trial sites expanded: 4 -> 54 locations 2026-07-25
Trial Details
NCT Number NCT07556159
Lead Sponsor Sanofi
Collaborators: Syneos Health
Conditions Asthma
Enrollment 2,500 participants
Start Date 2026-04-01
Primary Completion 2029-04-04 (estimated)
Study Completion 2029-04-04 (estimated)
Updated on ClinicalTrials.gov 2026-08-13